{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T02:46:41Z","timestamp":1789958801769,"version":"4.0.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2012,2,15]],"date-time":"2012-02-15T00:00:00Z","timestamp":1329264000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,2,15]],"date-time":"2012-02-15T00:00:00Z","timestamp":1329264000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1007\/s00277-012-1421-6","type":"journal-article","created":{"date-parts":[[2012,2,14]],"date-time":"2012-02-14T02:29:13Z","timestamp":1329186553000},"page":"1065-1072","source":"Crossref","is-referenced-by-count":14,"title":["Cytogenetic profile of 1,863 Ph\/BCR-ABL-positive chronic myelogenous leukemia patients from the Chinese population"],"prefix":"10.1007","volume":"91","author":[{"given":"Qitian","family":"Mu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuling","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yungui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangmin","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei-Fei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,15]]},"reference":[{"key":"1421_CR1","doi-asserted-by":"publisher","first-page":"973","DOI":"10.4065\/81.7.973","volume":"81","author":"A Quintas-Cardama","year":"2006","unstructured":"Quintas-Cardama A, Cortes JE (2006) Chronic myeloid leukemia: diagnosis and treatment. Mayo Clin Proc 81:973\u2013988","journal-title":"Mayo Clin Proc"},{"key":"1421_CR2","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1126\/science.3460176","volume":"233","author":"Y Benneriah","year":"1986","unstructured":"Benneriah Y, Daley GQ, Mesmasson AM, Witte ON, Baltimore D (1986) The chronic myelogenous leukemia specific P210-protein is the product of the Bcr\/Abl hybrid gene. Science 233:212\u2013214","journal-title":"Science"},{"key":"1421_CR3","doi-asserted-by":"publisher","first-page":"4603","DOI":"10.1182\/blood.V86.12.4603.bloodjournal86124603","volume":"86","author":"JW Voncken","year":"1995","unstructured":"Voncken JW, Kaartinen V, Pattengale PK, Germeraad WTV, Groffen J, Heisterkamp N (1995) Bcr\/Abl P210 and P190 cause distinct leukemia in transgenic mice. Blood 86:4603\u20134611","journal-title":"Blood"},{"key":"1421_CR4","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.1182\/blood-2003-12-4111","volume":"103","author":"B Calabretta","year":"2004","unstructured":"Calabretta B, Perrotti D (2004) The biology of CML blast crisis. Blood 103:4010\u20134022","journal-title":"Blood"},{"key":"1421_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0165-4608(93)90206-2","volume":"71","author":"HJ Ch'ang","year":"1993","unstructured":"Ch'ang HJ, Tien HF, Wang CH et al (1993) Comparison of clinical and biologic features between myeloid and lymphoid transformation of Philadelphia chromosome positive chronic myeloid leukemia. Cancer Genet Cytogenet 71:87\u201393","journal-title":"Cancer Genet Cytogenet"},{"key":"1421_CR6","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1002\/1097-0142(19870901)60:5<974::AID-CNCR2820600510>3.0.CO;2-1","volume":"60","author":"M Krulik","year":"1987","unstructured":"Krulik M, Smadja N, Degramont A et al (1987) Sequential karyotype study on Ph-positive chronic myelocytic-leukemia\u2014significance of additional chromosomal-abnormalities during disease evolution. Cancer 60:974\u2013979","journal-title":"Cancer"},{"key":"1421_CR7","first-page":"571","volume":"35","author":"K Michalova","year":"1988","unstructured":"Michalova K, Musilova J, Koudelova Z, Placerova J, Matuchova L (1988) Cytogenetic study of chronic myeloid leukemia. Neoplasma 35:571\u2013581","journal-title":"Neoplasma"},{"key":"1421_CR8","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.leukres.2008.07.019","volume":"33","author":"AG Reid","year":"2009","unstructured":"Reid AG, De Melo VA, Elderfield K et al (2009) Phenotype of blasts in chronic myeloid leukemia in blastic phase-analysis of bone marrow trephine biopsies and correlation with cytogenetics. Leuk Res 33:418\u2013425","journal-title":"Leuk Res"},{"key":"1421_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0165-4608(86)90134-2","volume":"22","author":"L Parreira","year":"1986","unstructured":"Parreira L, Kearney L, Rassool F et al (1986) Correlation between chromosomal-abnormalities and blast phenotype in the blast crisis of Ph-positive Cgl. Cancer Genet Cytogenet 22:29\u201334","journal-title":"Cancer Genet Cytogenet"},{"key":"1421_CR10","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.3324\/haematol.2009.019109","volume":"95","author":"E Lippert","year":"2010","unstructured":"Lippert E, Etienne G, Mozziconacci MJ et al (2010) Loss of the Y chromosome in Philadelphia-positive cells predicts a poor response of chronic myeloid leukemia patients to imatinib mesylate therapy. Haematologica 95:1604\u20131607","journal-title":"Haematologica"},{"key":"1421_CR11","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1038\/leu.2009.107","volume":"23","author":"Y Cheng","year":"2009","unstructured":"Cheng Y, Wang Y, Wang H et al (2009) Cytogenetic profile of de novo acute myeloid leukemia: a study based on 1432 patients in a single institution of China. Leukemia 23:1801\u20131806","journal-title":"Leukemia"},{"key":"1421_CR12","first-page":"1497","volume":"132","author":"PC Nowell","year":"1960","unstructured":"Nowell PC, Hungerford DA (1960) A minute chromosome in human chronic granulocytic leukemia. Science 132:1497","journal-title":"Science"},{"key":"1421_CR13","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/243290a0","volume":"243","author":"JD Rowley","year":"1973","unstructured":"Rowley JD (1973) New consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature 243:290\u2013293","journal-title":"Nature"},{"key":"1421_CR14","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.beha.2009.07.007","volume":"22","author":"M Rohrbacher","year":"2009","unstructured":"Rohrbacher M, Hasford J (2009) Epidemiology of chronic myeloid leukaemia (CML). Best Pract Res Clin Haematol 22:295\u2013302","journal-title":"Best Pract Res Clin Haematol"},{"key":"1421_CR15","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/leu.2008.245","volume":"23","author":"M Rohrbacher","year":"2009","unstructured":"Rohrbacher M, Berger U, Hochhaus A et al (2009) Clinical trials underestimate the age of chronic myeloid leukemia (CML) patients. Incidence and median age of Ph\/BCR-ABL-positive CML and other chronic myeloproliferative disorders in a representative area in Germany. Leukemia 23:602\u2013604","journal-title":"Leukemia"},{"key":"1421_CR16","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/pds.1046","volume":"14","author":"S Tardieu","year":"2005","unstructured":"Tardieu S, Brun-Strang C, Berthaud P et al (2005) Management of chronic myeloid leukemia in France: a multicentered cross-sectional study on 538 patients. Pharmacoepidemiol Drug Saf 14:545\u2013553","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1421_CR17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s12185-008-0230-0","volume":"89","author":"WY Au","year":"2009","unstructured":"Au WY, Caguioa PB, Chuah C et al (2009) Chronic myeloid leukemia in Asia. Int J Hematol 89:14\u201323","journal-title":"Int J Hematol"},{"key":"1421_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/08958370701758734","volume":"2","author":"HH Weng","year":"2008","unstructured":"Weng HH, Tsai SS, Chiu HF, Wu TN, Yang CY (2008) Association of childhood leukemia with residential exposure to petrochemical air pollution in Taiwan. Inhal Toxico 2:31\u201336","journal-title":"Inhal Toxico"},{"key":"1421_CR19","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1093\/aje\/kwj182","volume":"164","author":"CL Yu","year":"2009","unstructured":"Yu CL, Wang SF, Pan PC et al (2009) Residential exposure to petrochemicals and the risk of leukemia: using geographic information system tools to estimate individual-level residential exposure. Am J Epidemiol 164:200\u2013207","journal-title":"Am J Epidemiol"},{"key":"1421_CR20","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1289\/ehp.11257","volume":"116","author":"CM Wong","year":"2008","unstructured":"Wong CM, Vichit-Vadakan N, Kan H, Qian Z (2008) Public Health and Air Pollution in Asia (PAPA): a multicity study of short-term effects of air pollution on mortality. Environ Health Perspect 116:1195\u20131202","journal-title":"Environ Health Perspect"},{"key":"1421_CR21","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.cancergencyto.2009.05.010","volume":"194","author":"A Bennour","year":"2009","unstructured":"Bennour A, Sennana H, Laatiri MA, Elloumi M, Khelif A, Saad A (2009) Molecular cytogenetic characterization of variant Philadelphia translocations in chronic myeloid leukemia: genesis and deletion of derivative chromosome 9. Cancer Genet Cytogenet 194:30\u201337","journal-title":"Cancer Genet Cytogenet"},{"key":"1421_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1365-2141.1985.tb02960.x","volume":"59","author":"B Lowenberg","year":"1985","unstructured":"Lowenberg B, Hagemeijer A, Abels J (1985) Detection of the blastic crisis cell clone in chronic myeloid-leukemia. Br J Haematol 59:27\u201336","journal-title":"Br J Haematol"},{"issue":"Suppl 1","key":"1421_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3109\/10428199309047856","volume":"11","author":"F Mitelman","year":"1993","unstructured":"Mitelman F (1993) The cytogenetic scenario of chronic myeloid leukemia. Leuk Lymphoma 11(Suppl 1):11\u201315","journal-title":"Leuk Lymphoma"},{"key":"1421_CR24","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/0002-9343(87)90754-6","volume":"83","author":"HM Kantarjian","year":"1987","unstructured":"Kantarjian HM, Keating MJ, Talpaz M et al (1987) Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients. Am J Med 83:445\u2013454","journal-title":"Am J Med"},{"key":"1421_CR25","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1182\/blood-2008-03-144790","volume":"113","author":"A Quintas-Cardama","year":"2009","unstructured":"Quintas-Cardama A, Cortes J (2009) Molecular biology of bcr-abl1-positive chronic myeloid leukemia. Blood 113:1619\u20131630","journal-title":"Blood"},{"key":"1421_CR26","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1002\/cncr.21797","volume":"106","author":"CC Yin","year":"2006","unstructured":"Yin CC, Cortes J, Barkoh B, Hayes K, Kantarjian H, Jones D (2006) t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy. Cancer 106:1730\u20131738","journal-title":"Cancer"},{"key":"1421_CR27","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000046636","volume":"107","author":"B Johansson","year":"2002","unstructured":"Johansson B, Fioretos T, Mitelman F (2002) Cytogenetic and molecular genetic evolution of chronic myeloid leukemia. Acta Haematol 107:76\u201394","journal-title":"Acta Haematol"},{"key":"1421_CR28","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1200\/JCO.1996.14.1.196","volume":"14","author":"A Majlis","year":"1996","unstructured":"Majlis A, Smith TL, Talpaz M, O'Brien S, Rios MB, Kantarjian HM (1996) Significance of cytogenetic clonal evolution in chronic myelogenous leukemia. J Clin Oncol 14:196\u2013203","journal-title":"J Clin Oncol"},{"key":"1421_CR29","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1182\/blood-2002-03-0777","volume":"100","author":"ME O'Dwyer","year":"2002","unstructured":"O'Dwyer ME, Mauro MJ, Kurilik G et al (2002) The impact of clonal evolution on response to imatinib mesylate (STI571) in accelerated phase CML. Blood 100:1628\u20131633","journal-title":"Blood"},{"key":"1421_CR30","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1182\/blood-2003-02-0371","volume":"103","author":"ME O'Dwyer","year":"2004","unstructured":"O'Dwyer ME, Mauro MJ, Blasdel C et al (2004) Clonal evolution and lack of cytogenetic response are adverse prognostic factors for hematologic relapse of chronic phase CML patients treated with imatinib mesylate. Blood 103:451\u2013455","journal-title":"Blood"},{"key":"1421_CR31","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1002\/cncr.25015","volume":"116","author":"D Verma","year":"2010","unstructured":"Verma D, Kantarjian H, Shan J et al (2010) Survival outcomes for clonal evolution in chronic myeloid leukemia patients on second generation tyrosine kinase inhibitor therapy. Cancer 116:2673\u20132681","journal-title":"Cancer"},{"key":"1421_CR32","doi-asserted-by":"publisher","first-page":"6760","DOI":"10.1182\/blood-2011-08-373902","volume":"118","author":"A Fabarius","year":"2010","unstructured":"Fabarius A, Leitner A, Hochhaus A et al (2010) Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML study IV. Blood 118:6760\u20136768","journal-title":"Blood"},{"key":"1421_CR33","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1365-2141.2004.04899.x","volume":"125","author":"MM El-Zimaity","year":"2004","unstructured":"El-Zimaity MM, Kantarjian H, Talpaz M et al (2004) Results of imatinib mesylate therapy in chronic myelogenous leukaemia with variant Philadelphia chromosome. Br J Haematol 125:187\u2013195","journal-title":"Br J Haematol"},{"key":"1421_CR34","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.cancergencyto.2006.10.006","volume":"173","author":"M Gorusu","year":"2007","unstructured":"Gorusu M, Benn P, Li ZH, Fang M (2007) On the genesis and prognosis of variant translocations in chronic myeloid leukemia. Cancer Genet Cytogenet 173:97\u2013106","journal-title":"Cancer Genet Cytogenet"},{"key":"1421_CR35","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1182\/blood.V95.3.738.003k21_738_743","volume":"95","author":"PB Sinclair","year":"2000","unstructured":"Sinclair PB, Nacheva EP, Leversha M et al (2000) Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia. Blood 95:738\u2013743","journal-title":"Blood"},{"key":"1421_CR36","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1182\/blood.V98.6.1732","volume":"98","author":"BJ Huntly","year":"2001","unstructured":"Huntly BJ, Reid AG, Bench AJ et al (2001) Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia. Blood 98:1732\u20131738","journal-title":"Blood"},{"key":"1421_CR37","doi-asserted-by":"publisher","first-page":"6793","DOI":"10.1182\/blood-2011-01-328294","volume":"117","author":"G Marzocchi","year":"2011","unstructured":"Marzocchi G, Castagnetti F, Luatti S et al (2011) Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA WP on CML analysis. Blood 117:6793\u20136800","journal-title":"Blood"},{"key":"1421_CR38","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/ajh.2830270309","volume":"27","author":"JL Diezmartin","year":"1988","unstructured":"Diezmartin JL, Dewald GW, Pierre RV (1988) Possible cytogenetic distinction between lymphoid and myeloid blast crisis in chronic granulocytic-leukemia. Am J Hematol 27:194\u2013203","journal-title":"Am J Hematol"},{"key":"1421_CR39","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1471-2164-11-41","volume":"11","author":"EP Nacheva","year":"2010","unstructured":"Nacheva EP, Brazma D, Virgili A et al (2010) Deletions of immunoglobulin heavy chain and T cell receptor gene regions are uniquely associated with lymphoid blast transformation of chronic myeloid leukemia. Bmc Genomics 11:41","journal-title":"Bmc Genomics"},{"key":"1421_CR40","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00277-005-1099-0","volume":"84","author":"U Bacher","year":"2005","unstructured":"Bacher U, Kern W, Schnittger S, Hiddemann W, Schoch C, Haferlach T (2005) Further correlations of morphology according to FAB and WHO classification to cytogenetics in de novo acute myeloid leukemia: a study on 2,235 patients. Ann Hematol 84:785\u2013791","journal-title":"Ann Hematol"},{"key":"1421_CR41","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1046\/j.1365-2141.2001.02801.x","volume":"113","author":"MC Bene","year":"2001","unstructured":"Bene MC, Bernier M, Casasnovas RO et al (2001) Acute myeloid leukaemia MO: haematological, immunophenotypic and cytogenetic characteristics and their prognostic significance: an analysis in 241 patients. Br J Haematol 113:737\u2013745","journal-title":"Br J Haematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-012-1421-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-012-1421-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-012-1421-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-012-1421-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T17:04:05Z","timestamp":1713546245000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-012-1421-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,15]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["1421"],"URL":"https:\/\/doi.org\/10.1007\/s00277-012-1421-6","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,15]]}}}